Genmab A/S ADS GMAB
$43.79
+9.47%
at last close
Analyst Consensus
- Consensus Rating
- Buy (7 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $42.94
- Implied Upside
- -1.9%
- Price Target Range
- $32.00 – $58.00
- Analysts (12 mo)
- 8
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-07 | Truist SecuritiesAsthika Goonewardene |
Maintains | Buy | $40 → $45 |
| 2026-10-07 | GuggenheimMichael Schmidt |
Maintains | Buy | $54 → $58 |
| 2026-10-07 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $40 → $50 |
| 2026-10-05 | GuggenheimMichael Schmidt |
Maintains | Buy | $45 → $54 |
| 2026-09-14 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $40 |
| 2026-08-07 | GuggenheimMichael Schmidt |
Maintains | Buy | $40 → $42 |
| 2026-07-22 | TD CowenYaron Werber |
Upgrades | Hold → Buy | $32 → $43 |
| 2026-07-02 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $38 → $40 |
| 2026-06-23 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $38 |
| 2026-04-30 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $40 → $38 |
| 2026-03-27 | Wolfe ResearchKalpit Patel |
Initiates coverage on | Outperform | $32 |
| 2026-03-02 | Wells FargoEva Fortea Verdejo |
Initiates coverage on | Overweight | $40 |
| 2026-02-23 | GuggenheimMichael Schmidt |
Maintains | Buy | $45 → $40 |
| 2026-02-18 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $39 → $40 |
| 2026-02-17 | JefferiesBenjamin Jackson |
Reinstates | Buy | $42 |
| 2026-02-16 | Morgan StanleyJudah Frommer |
Reinstates | Equal-weight | $34 |
| 2026-01-28 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $39 |
| 2026-01-20 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $41 → $39 |
| 2025-11-10 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $40 → $41 |
| 2025-11-07 | Truist SecuritiesAsthika Goonewardene |
Reiterates | Buy | $49 → $48 |
| 2025-10-15 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $40 |
| 2025-10-02 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $36 → $40 |
| 2025-09-24 | GuggenheimMichael Schmitz |
Upgrades | Neutral → Buy | $43 |
| 2025-09-23 | GuggenheimMichael Schmidt |
Upgrades | Neutral → Buy | $43 |
| 2025-08-15 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $35 → $36 |
| 2025-07-08 | Truist SecuritiesAsthika Goonewardene |
Maintains | Buy | $45 → $46 |
| 2025-04-09 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $50 → $37 |
| 2025-03-11 | Truist SecuritiesAsthika Goonewardene |
Maintains | Buy | $50 → $45 |
| 2025-03-11 | William BlairMatt Phipps |
Upgrades | Market perform → Outperform | — |
| 2025-02-13 | Leerink PartnersJonathan Chang |
Upgrades | Market perform → Outperform | $27 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $43.79
- Market Cap
- $26.93 billion
- 52-Week Range
- $23.62 – $44.34
- Average Volume
- 4.14 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.